Conclusions
GERD, HGP1705
GERD
In conclusion, the findings of this study support the efficacy and safety of HIP1601 40 mg as a treatment option for EE healing and alleviating GERD symptoms. The results indicate that HIP1601 is not inferior to HGP1705 40 mg in terms of both efficacy and safety, as demonstrated by comparable healing rates and tolerability profiles. Based on these results, it can be concluded that HIP1601 is effective and well tolerated in patients with GERD.